Vest in Biological Technology

Hill-Rom Innovative Envision(R) E700 Wound Surface Receives Gold Medical Device Excellence Award

...atric Plus therapy system and before that received the 2007 Medical Device Excellence Award for The Vest(R) Airway Clearance System, Model 205. The vest System is a device to help patients with respiratory conditions clear airway secretions. About Hill-Rom Hill-Rom is a leading worldwide ma...

Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer

...res of Company common stock, at an exercise price equal to the fair market value of the stock as of May 20, 2009, the date of grant. The options will vest in equal annual installments over a four-year period or upon an earlier change in control of the Company. About Keryx Biopharmaceuticals, Inc...

Helix BioPharma Announces Q2 2009 Financial Results

...t of the issuance of 2,070,000 stock options to purchase common stock of the Company at an exercise price of $1.68, on December 17, 2008. The options vest 25% immediately, and 25% at each anniversary date thereafter. The stock-based compensation expense in the three and six month periods ended January 3...

VIA Pharmaceuticals Secures Financing Up to $10.0 Million

...at $0.12 per share (the "Warrants"). The Warrants vest based on the amount of borrowings under the loan a...y vested with respect to 8,333,333 shares and will vest with respect to an additional 8,333,333 shares 45 ...ided for in the Loan Agreement. The Warrants will vest with respect to additional shares in connection wi...

New Radiation-Blocking Medical Garments Introduced at RSNA Meeting in Chicago : Demron-M Technology Provides Total Protection in a Lightweight, Durable, Flexible Fabric

... while performing procedures or holding patients, the shields provide protection without reducing mobility. Demron-M Drop-Off Flex Apron and Two-Piece vest and Skirt, the most lightweight one-piece and two-piece garments available that help clinicians work comfortably for long periods. Used by physicians ...

Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units

...t recognize these certifications. InnerCool's CoolBlue(TM) surface temperature modulation system, which includes a console and a disposable CoolBlue vest with upper thigh pads, is designed to provide a complementary tool for use in less acute patients or in clinical settings best suited to prolonged tem...

Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System

...ature modulation system, which includes a console and a disposable CoolBlue vest with upper thigh pads, is designed to provide a complementary tool for use ...tings best suited to prolonged temperature management. InnerCool's CoolBlue vest and thigh pads wrap the body without requiring any adhesives to stick to th...

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350

...he grant date. The options have a 10 year term and vest over four years as follows: 20 percent of these options will vest on the date one year from the optionee's hire date, 20 percent of the options will vest in monthly increments during each of the second an...

Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification

...ature modulation system, which includes a console and a disposable CoolBlue vest with upper thigh pads, is designed to provide a complementary tool for use ...tings best suited to prolonged temperature management. InnerCool's CoolBlue vest and thigh pads wrap the body without requiring any adhesives to stick to th...

Cardium's InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems

...ature modulation system, which includes a console and a disposable CoolBlue vest with upper thigh pads, is designed to provide a tool for use in less acute ...tings best suited to prolonged temperature management. InnerCool's CoolBlue vest and thigh pads wrap the body without requiring any adhesives to stick to th...

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350

...he grant date. The options have a 10 year term and vest over four years as follows: 20 percent of these options will vest on the date one year from the optionee's hire date, 20 percent of the options will vest in monthly increments during each of the second an...

Cardium Reports on Science Channel Series Featuring InnerCool's Endovascular Cooling During Brain Surgery at Stanford University

...e modulation system, which includes a console and a disposable CoolBlue(TM) vest with upper thigh pads, is designed to provide a complementary tool for use ...tings best suited to prolonged temperature management. InnerCool's CoolBlue vest and thigh pads wrap the body without requiring any adhesives to stick to th...

Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems

...which includes a console and a disposable CoolBlue vest with upper thigh pads, is designed to provide a to...onged temperature management. InnerCool's CoolBlue vest and thigh pads wrap the body without requiring any...h includes a console and a disposable CoolBlue(TM) vest with upper thigh pads, is designed to provide a co...

Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer

...r share equal to the fair market value of the Company's common stock on April 1, 2008. The inducement option, which will have a term of 10 years, will vest with respect to one-eighth of the underlying shares six months after the date of grant and then with respect to the remaining shares ratably over the ...

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350

...he grant date. The options have a 10 year term and vest over four years. Except as otherwise noted, the options vest as follows: 20 percent of these options will vest ...tionee's hire date, 20 percent of the options will vest in monthly increments during each of the second an...

Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development

...any's 2006 Employment Commencement Incentive Plan, vest over four years as follows: 25 percent of the shares will vest on the one year anniversary of the grant date, and the remaining 75 percent will vest in 36 equal monthly increments during each of the ...

CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350

...he grant date. The options have a 10 year term and vest over four years as follows: 20 percent of these options will vest on the date one year from the optionee's hire date, 20 percent of the options will vest in monthly increments during each of the second an...

Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense

...ense of approximately $1.7 million. The Company recorded non- cash share-based compensation expense related to these options as if the options were to vest over a two-year period, as had been the case with earlier option grants to the Company's non-employee directors. Accordingly, in the third quarter of ...

Beware the Dreaded Off-Site Technology Meeting

...ime between sessions, you learn a lot of juicy gossip that you didn't hear back at the office. If you're lucky, you might also snag a new polar fleece vest or one of those engraved pens in the useless wood-carved holders. My off-site horror story took place in a start-up a few years ago. I was held up...